ALPN
Alpine Immune Sciences Inc
Halal Rating :
Last Price
$65.00
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing innovative, protein-based immunotherapies targeting the immune synapse to treat cancer, autoimmune/inflammatory disorders, and other diseases. The company is developing its lead product candidate povetacicept (ALPN-303) for the treatment of multiple autoimmune diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| March 31, 2024 | $7.03m | $29.73m | - | - | 0.00% | 0.00% |
| Dec. 31, 2023 | $30.85m | $29.31m | - | - | 0.00% | 0.00% |
| Sept. 30, 2023 | $10.04m | $24.59m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Alpine Immune Sciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.